PSMB4 and melanoma: Notably, PSMB4 (proteasome subunit beta type-4), a protein of the ubiquitin-proteasome degradation pathway, has been identified as the first proteasomal subunit with oncogenic properties and associated to poor prognosis in several tumors including melanoma, breast and ovarian cancers30-33.